Efficacy of thoracic wall block for breast cancer operation -randomized double blind study-.
Phase 3
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000013435
- Lead Sponsor
- iigata University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
The patient who disagree to participate in this study ASA-physical status =/>4 The patient who has difficulty for communication (eg. patient suffered from dementia, has mental retardation, can not understand Japanese) Body Mass Index >30kg/m2 Body Weight<40kg The patient has allergy for the drugs that will use in this study Renal dysfunction or hepatic dysfunction The patient who has abnormal sensation or hypoesthesia in body trunk The patient who is received opioid medication The patient whom the examiner assume inadequate to participate in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method intraoperative: dose of anesthetics (propofol) and opioid (remifentanil) postoperative: incidence of usage of adjuvant analgesics and spontaneous pain scale (numerical rating scale)
- Secondary Outcome Measures
Name Time Method intraoperative: anesthetic induction time postopreative: incidence and degree of postoperative nausea and vomiting, incidence of adverse event and incidence and degree of persistent postoperative pain at 1,3 and 6 month after surgery